Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Outlook Therapeutics, Inc. - Common Stock (NQ:OTLK)

0.5778 +0.0078 (+1.37%)
Delayed Quote Updated: 3:09 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Outlook Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Thursday's after hours session: top gainers and losers ↗
After the conclusion of the US market's regular session on Thursday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
News headline image
Coinbase To Rally Over 11%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
 
Via Benzinga
News headline image
Top 3 Health Care Stocks That Could Blast Off This Month ↗
 
Via Benzinga
News headline image
Outlook Therapeutics Vision Loss Drug At Par With Novartis Drug ↗
Outlook Therapeutics plans to resubmit ONS-5010 for FDA approval in 2025 following NORSE EIGHT trial results in wet AMD patients. 
Via Benzinga
News headline image
This Kohl's Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Nasdaq Down Over 100 Points; HP Shares Plunge ↗
 
Via Benzinga
News headline image
Dow Falls Over 100 Points; US Crude Oil Stocks Decline ↗
 
Via Benzinga
Topics Stocks
News headline image
US Stocks Mixed; Economy Grows By 2.8% In Q3 ↗
 
Via Benzinga
Topics Economy
News headline image
Why Is Eye Disease-Focused Outlook Therapeutics Stock Trading Lower On Wednesday? ↗
Outlook Therapeutics reports ONS-5010 missed noninferiority endpoint in NORSE EIGHT trial for wet AMD but showed vision improvement and safety profile. 
Via Benzinga
News headline image
OUTLOOK ALERT: Bragar Eagel & Squire, P.C. is Investigating Outlook Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
OTLK Stock Earnings: Outlook Therapeutics Beats EPS for Q3 2024 ↗
OTLK stock results show that Outlook Therapeutics beat analyst estimates for earnings per share the third quarter of 2024. 
Via InvestorPlace
News headline image
3 Beaten Down Pharmaceuticals With Catalysts for Higher Prices
Beaten-down stocks offer value to investors, but not all are worth buying. This is a look at three biopharma at long-term lows with catalysts for higher prices. 
Via MarketBeat
News headline image
3 Undervalued Gems Set to Soar 1,000% by 2026 ↗
Discover the fundamentals behind three undervalued stocks to buy in the oil and gas, advertising, and biotechnology industries. 
Via InvestorPlace
News headline image
MarketBeat Week in Review – 6/17 - 6/21
Markets were calmer this week, with the Dow index posting the biggest gains, but it's too early to tell if this is the start of a broader market rally 
Via MarketBeat
Topics Economy Stocks
News headline image
Outlook Therapeutics: Analysts Forecast Over 500% Stock Upside
Outlook Therapeutics (NASDAQ: OTLK) has gained attention, with analysts forecasting an upside of over 500% based on the consensus price target. 
Via MarketBeat
News headline image
OTLK Stock Earnings: Outlook Therapeutics Misses EPS for Q2 2024 ↗
OTLK stock results show that Outlook Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
News headline image
Biotech on a Budget: 7 Stocks Under $10 With Huge Potential ↗
With the medical care industry always liable for negative surprises, you might as well go for big upside with under-$10 biotech stocks. 
Via InvestorPlace
News headline image
Insiders Buying Outlook Therapeutics And 2 Other Stocks ↗
Although U.S. stocks closed mixed on Thursday, there were a few notable insider trades. 
Via Benzinga
News headline image
Gold Moves Lower; Lululemon Shares Plummet ↗
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 0.3% on Friday. The Dow traded down 0.49% to 39,585.67 while the NASDAQ rose 0.26% to 16,444.91. The S&P 500... 
Via Benzinga
Topics Stocks
News headline image
Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected fourth quarter adjusted EPS results. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Dow Dips 200 Points; Nike Shares Fall After Q3 Results ↗
U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 200 points. The Dow traded down 0.54% to 39,565.50 while the NASDAQ rose 0.04% to 16,408.74. The S&P 500 also... 
Via Benzinga
Topics Stocks
News headline image
Why Is Eye Disease-Focused Outlook Therapeutics Stock Trading Higher On Friday? ↗
Outlook Therapeutics stock sees uptick as European Medicines Agency committee issues positive opinion on ONS-5010/LYTENAVA for wet age-related macular degeneration (wet AMD). Strong trading volume... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Over $1.7M Bet On Globalstar? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying ↗
The Dow Jones index closed higher by around 47 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
News headline image
7 of the Best Speculative Stocks You Can Snag for Less Than $1 ↗
Although speculative stocks under $1 are by their very nature extremely risky, these ideas might have enough to go the distance. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.